Source: Markets Insider

NovaBiotics: NovaBiotics Announces First Patient Enrollment into the Cysteamine Domain of REMAP-CAP

ABERDEEN, Scotland, Dec. 8, 2021 /PRNewswire/ -- NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies ...

Read full article »
NovaBiotics's Competitors | NovaBiotics's News | NovaBiotics's Financials
Stay up-to-date with the latest news on NovaBiotics
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Deborah O'Neil's photo - Founder & CEO of NovaBiotics

Founder & CEO

Deborah O'Neil

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on NovaBiotics